Replies to post #507299 on Anavex Life Sciences Corp (AVXL)

[baltimorebullet]

Do you think they are allowed (at some point in the entire process) to point to the safety data of fragile little Rett girls and PDD sufferers (who are probably worse off than Alzheimer's sufferers) ?

[tradeherpete]

Two Rapporteurs had the data for 210 days, then 30 additional Rapporteurs saw the data for one day.

This stirred up some controversy which Anavex attempted to straighten out the following day for one hour.

It’s a lot to expect for 30 people to change their lifetime beliefs in an hour or two.

I can understand how they need more time. Hopefully they will see the light in the coming weeks.

They have a lot on their plate in addition to Blarcamesine, there could be pressure from Big Pharma to deny the application, any number of things could be at play but it’s clear the data is very strong and supports approval.